Previous 10 |
home / stock / bictf / bictf news
Vancouver, British Columbia--(Newsfile Corp. - October 14, 2020) - BioCure Technology Inc. (CSE: CURE) ("BioCure" or the "Company") announces that it will close a non-brokered private placement (the "Private Placement") on October 15th, 2020 consisting of 1,786,725 Units at a price of $0.14 ce...
Vancouver, British Columbia--(Newsfile Corp. - September 21, 2020) - Biocure Technology Corp. (CSE: CURE) (OTCQB: BICTF) ("CURE" or the "Company") BiocurePharm, Korea ("BPK"), a subsidiary of Biocure Technology Inc. ("CURE") is pleased to announce that BPK has entered into a non-binding M...
Vancouver, British Columbia--(Newsfile Corp. - September 10, 2020) - Biocure Technology Corp. (CSE: CURE) (OTCQB: BICTF) ("CURE" or the "Company") BiocurePharm, Korea ("BPK"), a subsidiary of Biocure Technology Inc. ("CURE") is pleased to announce that they have been actively pursui...
Vancouver, British Columbia--(Newsfile Corp. - January 20, 2020) - Biocure Technology Corp. (CSE: CURE) (OTCQB: BICTF) ("CURE" or the "Company") BiocurePharm, Korea ("BPK"), a subsidiary of Biocure Technology Inc. ("CURE") is pleased to announce that it has closed its non-brokered private pl...
Vancouver, British Columbia--(Newsfile Corp. - October 17, 2019) - Biocure Technology Inc. (CSE: CURE) (OTCQB: BICTF) (the " Company " or " Biocure ") is pleased to announce that Biocure Pharm Corp.("BPK"), a subsidiary of the Company has appointed CLIPS (Clinical Professional Services) as ...
Vancouver, British Columbia--(Newsfile Corp. - September 19, 2019) - Biocure Technology Corp. (CSE:CURE) (OTCQB: BICTF) ("CURE" or the "Company") wishes to correct its earlier press release of today's date to advise that it has closed its Convertible Debenture financing through its Korean Subs...
Vancouver, British Columbia--(Newsfile Corp. - September 19, 2019) - BiocurePharm, Korea ("BPK"), a wholly owned subsidiary of Biocure Technology Corp. (CSE: CURE) (OTCQB: BICTF) ("CURE" or the "Company") is pleased to announce that it has closed its Convertible Debenture financing through its...
Vancouver, British Columbia--(Newsfile Corp. - July 11, 2019) - Biocure Technology Corp. (CSE: CURE) (OTCQB: BICTF) ("CURE" or the "Company") BiocurePharm, Korea ("BPK"), a wholly owned subsidiary of Biocure Technology Inc. ("CURE") is pleased to announce that it has closed its non-brokered pr...
Vancouver, British Columbia--(Newsfile Corp. - May 16, 2019) - Biocure Technology Inc. (CSE: CURE) (OTCQB: BICTF) (formerly Gravis Energy Corp.) (the " Company " or " Biocure ") is pleased to announce that Biocure Pharm Corp.("BPK"), a subsidiary of the Company has entered into an agreement wi...
News, Short Squeeze, Breakout and More Instantly...
Biocure Technology Inc Company Name:
BICTF Stock Symbol:
OTCMKTS Market:
Biocure Technology Inc Website:
Vancouver, British Columbia--(Newsfile Corp. - September 18, 2023) - Biocure Technology Inc. (CSE: CURE) ("CURE" or the "Company") announces that it has entered into an exclusive letter agreement dated September 8, 2023 with Atriva Therapeutics GmbH. ("Atriva") whereby the Company will acquire al...
Vancouver, British Columbia--(Newsfile Corp. - March 25, 2022) - Biocure Technology Inc. (CSE: CURE) (OTCQB: BICTF) ("Biocure" or the "Company") is pleased to provide the following operational and investment update to the market and its stakeholders. BPK is currently under way to develop ROR...
Vancouver, British Columbia--(Newsfile Corp. - December 2, 2021) - Biocure Technology Corp. (CSE: CURE) (OTCQB: BICTF) ("Biocure" or the "Company") is pleased to provide the following operational and investment update to the market and its stakeholders. The Company continues to build financi...